Streetbeat News

Products Services

TGTX

TG Therapeutics, Inc. (NASDAQ:TGTX) has presented data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS) at the 2023 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting. The data highlights the unique attributes of BRIUMVI and includes the first data from the ENHANCE trial evaluating patients who switch from an IV anti-CD20 antibody to BRIUMVI.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 2:31 pm

SMCI

Supermicro's senior solutions manager, Alok Kumar Srivastav, highlighted the role of AI in the next industrial revolution during an interview with DIGITIMES Asia. He emphasized the importance of digital data creation, storage, and processing in AI development. Srivastav also discussed Supermicro's partnerships with Nvidia, Intel, and AMD, and the company's role in supplying computing units to major corporations across various industries. He predicted that AI adoption will become a necessity for survival in the modern marketplace.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 2:27 pm

ERJ

Luxair, the flag carrier of Luxembourg, has signed a firm order for four E195-E2 aircraft from Embraer (NYSE:ERJ). The aircraft will complement Luxair's larger narrowbody aircraft recently ordered. Luxair also secured two options and three purchase rights for more aircraft, with conversion rights to E190-E2 as required. The first aircraft delivery is scheduled for Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 2:18 pm

MLTX

MoonLake Immunotherapeutics (NASDAQ:MLTX) has presented positive 12-week data from its Phase 2 MIRA trial of Nanobody Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress. The trial met its primary endpoint with a significantly higher proportion of patients treated with sonelokimab achieving HiSCR75 compared to those on placebo. The safety profile of sonelokimab was consistent with previously reported studies. The company anticipates 24-week data from the trial imminently.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 2:17 pm

HYMTF

TSLA

Ford Motor Co (NYSE:F), Hyundai Motor Company (OTC:HYMTF), and another European automotive entity have onboarded Idra, an Italian firm known for crafting aluminum casting machines and being a noted supplier for Tesla Inc (NASDAQ:TSLA). This highlights a growing interest in the use of gigantic casting machines, or 'gigapresses', for the production of substantial single pieces for vehicle underbodies. This technique streamlines the manufacturing process and reduces the workload, even for robots. Idra has dispatched 14 presses to Tesla, two of which are designated for its large Cybertruck production at its Texas facility.

Portfolio Pulse from Shivani Kumaresan

October 11, 2023 | 2:15 pm

AAPL

META

Meta Platforms Inc. is planning the successor to its Quest 3 VR headset, taking cues from Apple's Vision Pro. The company's focus has shifted from the metaverse to the practical applications of its VR headset, aligning its strategy with Apple's. Meta's stock has increased by 162% this year, with a 7% gain in October.

Portfolio Pulse from Zaheer Anwari

October 11, 2023 | 2:07 pm

FUV

KNDI

LCID

NIO

PSNY

RIVN

SOLO

TSLA

XPEV

According to the EIA Administrator, electric vehicle sales are projected to reach 2 billion by 2050. Meanwhile, sales of internal combustion engine vehicles are expected to peak between 2027 and 2033.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 2:03 pm

IZEA

IZEA Worldwide has launched AI Image Manipulation in FormAI, a feature designed to revolutionize how creators produce visual content. The AI technology allows creators to isolate subjects of their images by removing the background, replace backgrounds with new environments, and modify and transform their images with a single click.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 2:01 pm

BAX

DVA

FMS

LLY

NVO

Shares of DaVita Inc (DVA), Fresenius Medical Care AG (FMS), and Baxter International Inc (BAX) fell sharply due to Novo Nordisk A/S's (NVO) early termination of its semaglutide kidney outcomes trial FLOW due to early signs of efficacy. The GLP-1 drugs like semaglutide could potentially reduce the size of the dialysis patient population over time, negatively impacting the dialysis market. The announcement also strengthens the case for using GLP-1 drugs, including Eli Lilly And Co's (LLY) Mounjaro, in diabetes patients with chronic kidney disease.

Portfolio Pulse from Vandana Singh

October 11, 2023 | 1:53 pm

ADBE

Adobe has previewed Project Stardust, a generative AI-powered object-aware editing engine that allows users to move or remove objects in images by clicking on them. The company showcased 11 early-stage innovations, including new generative AI capabilities across photo, video, and audio use cases, as well as 3D, design, and fashion applications.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:49 pm